Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Selective isolation of biopharmaceuticals with fluid zwitterionic polymeric coacervates

Project description

Novel purification method for gene therapy vehicles

Gene therapy holds enormous potential for treating debilitating diseases, but manufacturing the viral particles that deliver genetic material remains a major challenge. In particular, improved purification methods are needed to guarantee purity, structural integrity and batch-to-batch consistency, which are critical for both safety and efficacy. The ERC-funded CAPTOMER project proposes a novel isolation technique using programmable, liquid-like materials called coacervates. Made from specialised polymers, these gentle materials can selectively capture the viral particles while preserving their integrity during purification. Previously tested on other biological nanoparticles, this scalable method has shown improvements in purity, yield and processing time. The CAPTOMER method could transform the manufacture of gene therapy products and advance next-generation therapeutic strategies.

Objective

"Gene therapy and RNA-based therapeutics hold significant promise for treating a range of debilitating disorders. A key challenge for these therapies is the effective targeted delivery, which relies on nanovehicles to ensure the stability of the delicate nucleic acids involved. Biogenic nanoparticles, such as adeno-associated viruses (AAVs), are becoming increasingly promising for these applications, with some AAV-based therapies already receiving regulatory approval. However, maintaining the physicochemical properties essential for the efficacy and safety of these products presents significant challenges, particularly due to their complex manufacturing processes, which often result in a high degree of impurities or perturbations in their structures. Traditional bioseparation methods, such as chromatography, struggle to efficiently isolate these nanoparticles without compromising their quality.
To address these issues, this project proposes a novel isolation technique for AAVs using functionalized, programmable liquid-like coacervates formed from zwitterionic polymers. Previous applications on extracellular vesicles demonstrated significant improvements in purity, yield, and processing time compared to conventional methods. The liquid nature of coacervates preserves particle integrity during isolation while their anti-fouling properties enhance specificity in capturing target molecules. This scalable approach integrates the benefits of existing purification methods, offering a gentler, efficient, and simple solution for bioseparation.
Building on the success of the Consolidator ERC-funded ""VELCROproteins"" project, this initiative translates insights obtained from biological condensate research to design coacervates with tunable properties for diverse biotechnological applications, particularly in the healthcare sector. The project aims to establish a new purification processes for crucial nanomaterials, paving the way for advanced therapeutic strategies."

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-POC

See all projects funded under this call

Host institution

EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH
Net EU contribution
€ 150 000,00
Address
Raemistrasse 101
8092 Zuerich
Switzerland
Region
Schweiz/Suisse/Svizzera Zürich Zürich
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)